Portal de Periódicos da CAPES

Potential drug–drug interactions associated with drugs currently proposed for COVID‐19 treatment in patients receiving other treatments

2020; Wiley; Volume: 34; Issue: 5 Linguagem: Inglês

10.1111/fcp.12586

1472-8206

F. Lemaı̂tre, Caroline Solas, Matthieu Grégoire, Laurence Lagarce, Laure Elens, Élisabeth Polard, Béatrice Saint–Salvi, Agnès Sommet, Michel Tod, Chantal Barin‐Le Guellec,

Antibiotics Pharmacokinetics and Efficacy

Patients with COVID-19 are sometimes already being treated for one or more other chronic conditions, especially if they are elderly. Introducing a treatment against COVID-19, either on an outpatient basis or during hospitalization for more severe cases, raises the question of potential drug-drug interactions. Here, we analyzed the potential or proven risk of the co-administration of drugs used for the most common chronic diseases and those currently offered as treatment or undergoing therapeutic trials for COVID-19. Practical recommendations are offered, where possible.